What is Monte Rosa Therapeutics, Inc.'s price / sales?

Monte Rosa Therapeutics, Inc. (GLUE) reported price / sales of 30.6× in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s price / sales changed year-over-year?

Monte Rosa Therapeutics, Inc.'s price / sales increased by 1612.4% year-over-year, from 1.8× to 30.6×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Monte Rosa Therapeutics, Inc. GLUE Price / sales

Price / sales at other companies

Bristol-Myers SquibbBMY

2.6×-0.1×

Nurix Therapeutics, Inc.NRIX

22.9×+2.1×

Kymera TherapeuticsKYMR

132.1×+102×

ImmunomeIMNM

616.2×+563×

Adaptive BiotechnologiesADPT

7.2×+1.4×

Arcus BiosciencesRCUS

11.5×+5.6×

Other financials

Income statement

See full

Revenue$4.2M-95.0%

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.75B+361%

Enterprise value$1.63B+381%

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.

market cap/total revenue=30.6×

Based on the most recent quarter.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s price / sales?: Monte Rosa Therapeutics, Inc. (GLUE) reported price / sales of 30.6× in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s price / sales changed year-over-year?: Monte Rosa Therapeutics, Inc.'s price / sales increased by 1612.4% year-over-year, from 1.8× to 30.6×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.